Why Phreesia Stock Tumbled Today
Although its net income rose sharply, analysts expected better. On a brighter note, the company slightly topped the consensus pundit estimate for revenue.
The Motley Fool9/3/2026Neutral
PHR
Phreesia IncNYSEHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$679.06M
P/E Ratio
60.78
EPS
$0.18
Beta
0.86
52W High
$27.11
52W Low
$7.77
50-Day MA
$11.24
200-Day MA
$12.29
Dividend Yield
—
Profit Margin
2.06%
Forward P/E
14.79
PEG Ratio
—
About Phreesia Inc
Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.
Fundamentals
| Revenue (TTM) | $507.79M |
| Gross Profit (TTM) | $342.86M |
| EBITDA | $43.76M |
| Operating Margin | 5.88% |
| Return on Equity | 3.12% |
| Return on Assets | 2.58% |
| Revenue/Share (TTM) | $8.35 |
| Book Value | $5.81 |
| Price-to-Book | 1.85 |
| Price-to-Sales (TTM) | 1.34 |
| EV/Revenue | 1.346 |
| EV/EBITDA | 13.66 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | 10.40% |
| Shares Outstanding | $62.07M |
| Float | $49.18M |
| % Insiders | 6.27% |
| % Institutions | 96.20% |
Historical Volatility
HV 10-Day
44.43%
HV 20-Day
44.13%
HV 30-Day
52.55%
HV 60-Day
51.28%
HV Rank
57.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
3
Strong Buy8
Buy8
HoldLatest News
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
Seeking Alpha9/2/2026Neutral
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research9/2/2026Positive
Phreesia Announces Second Quarter Fiscal 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia delivered a solid fiscal second quarter, with revenue growth and profitability expansion in line with our expectations. We generated positive operating and free cash flow again this quarter, which together with available cash allowed us to reduce debt principal by over $23 million while maint.
Business Wire9/2/2026Neutral
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.
GlobeNewsWire8/4/2026Neutral
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and whether legal remedies may be available.
GlobeNewsWire7/29/2026Neutral
Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia and March of Dimes announce a partnership to enhance critical physician-patient conversations during prenatal and postpartum appointments.
Business Wire7/23/2026Neutral
Should Value Investors Buy Phreesia (PHR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research7/21/2026Positive
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
PRNewsWire7/16/2026Neutral
PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you currently own shares of Phreesia, Inc. (NYSE: PHR)? Did you purchase any of your shares prior to May 8, 2025?
GlobeNewsWire7/16/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PHR and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026